Applications, hearings, determinations, etc.: Sigma Aldrich Research Biochemicals, Inc.,

[Federal Register: March 5, 1999 (Volume 64, Number 43)]

[Notices]

[Page 10725]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr05mr99-100]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that in a letter dated January 20, 1999, Sigma Aldrich Research Biochemicals, Inc., Attn: Richard Milius, 1-3 Strathmore Road, Natick, Massachusetts 01760, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of fentanyl (9801), a basic class of controlled substance in Schedule II.

The firms plans to synthesize the fentanyl molecule to produce small quantities of fentanyl free base.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than May 4, 1999.

Dated: February 23, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 99-5407Filed3-4-99; 8:45 am]

BILLING CODE 4410-09-M